Drug Development Under Siege
AEI Newsletter

Pharmaceutical Price Regulation Developing new, effective drugs is staggeringly expensive, and the high prices of certain drugs on the market are directly related to this initial investment, John A. Vernon and Joseph H. Golec explain in Pharmaceutical Price Regulation: Public Perceptions, Economic Realities, and Empirical Evidence (AEI Press, January 2009). According to Vernon and Golec, "the average cost of bringing a single new drug to the marketplace--covering years or even decades of research and development, safety tests, clinical trials, and regulatory approval--is about $1 billion." Drug and biotechnology firms, they point out, can only recoup this enormous investment if a drug successfully goes to market.

Politicians and activists who want to see pharmaceutical prices controlled do not understand the crucial role of high prices in the drug development process. Vernon and Golec show that there is a direct link between price controls and reduction in drug R&D. Price controls harm pharmaceutical development by robbing firms of the incentive to conduct R&D to develop new drugs. The authors offer Europe's experiment with price controls as an example of the ill effects of this kind of regulatory tampering. Spending on drug R&D has dropped dramatically in Europe since the European Union instituted price controls. "Drug development is under siege," they warn.

"The prices set by the free market are the signals that corporations need in order to decide whether to undertake expensive, risky research into new drugs," the authors insist. They argue against tampering with the current system for drug development and pricing. "Despite its flaws, it is better than any other in existence in countries with single-payer (i.e., government) systems." Vernon and Golec caution that enacting policy based on the short-term gains that result from lower, government-controlled prices would hamper the development of life-saving drugs in the future.

For more information about this book, visit www.aei.org/book972/.

Also Visit
AEIdeas Blog The American Magazine

What's new on AEI

image The money in banking: Comparing salaries of bank and bank regulatory employees
image What Obama should say about China in Japan
image A key to college success: Involved dads
image China takes the fight to space
AEI on Facebook
Events Calendar
  • 21
    MON
  • 22
    TUE
  • 23
    WED
  • 24
    THU
  • 25
    FRI
Wednesday, April 23, 2014 | 12:00 p.m. – 1:30 p.m.
Graduation day: How dads’ involvement impacts higher education success

Join a diverse group of panelists — including sociologists, education experts, and students — for a discussion of how public policy and culture can help families lay a firmer foundation for their children’s educational success, and of how the effects of paternal involvement vary by socioeconomic background.

Event Registration is Closed
Thursday, April 24, 2014 | 12:00 p.m. – 1:30 p.m.
Getting it right: A better strategy to defeat al Qaeda

This event will coincide with the release of a new report by AEI’s Mary Habeck, which analyzes why current national security policy is failing to stop the advancement of al Qaeda and its affiliates and what the US can do to develop a successful strategy to defeat this enemy.

Friday, April 25, 2014 | 9:15 a.m. – 1:15 p.m.
Obamacare’s rocky start and uncertain future

During this event, experts with many different views on the ACA will offer their predictions for the future.   

No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.